ACAN - Tissue Dissociator

AMENDMENT TO RESPONSE DEADLINE CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time. All required supporting documentation and statement of capabilities must be submitted by 08 May 2024 at 14:00 EDT. All statement of capabilities submitted after 14:00 EDT will result in the statement of capability being declared non-responsive. Health Canada requires a Tissue Dissociator to conduct regulatory research on vaccines against pathogens such as influenza, respiratory syncytial virus, Lyme disease and SARS-CoV-2. Any interested supplier must demonstrate by way of a statement of capabilities that its product/equipment/system (as appropriate) meets the specifications listed in the ACAN document.